Tokyo Tape
Sign in
← M3

Quarterly report · Q2

2413.TEDINET S100PJMD
Period2022-04-01 → 2022-09-30
Filed2022-11-11
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥112.6bn2022-04-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥55.6bn2022-07-01 → 2022-09-30dCons.Revenue IFRS
Revenue¥208.2bn2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥97.6bn2021-04-01 → 2021-09-30Cons.Revenue IFRS
Revenue¥51.2bn2021-07-01 → 2021-09-30dCons.Revenue IFRS
Operating income¥36.3bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥17.6bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Operating income¥61.9bn2021-04-01 → 2021-09-30Cons.Operating profit loss IFRS
Operating income¥37.3bn2021-07-01 → 2021-09-30dCons.Operating profit loss IFRS
Profit before tax¥38.1bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥18.3bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Profit before tax¥96.2bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥62.2bn2021-04-01 → 2021-09-30Cons.Profit loss before tax IFRS
Profit before tax¥37.5bn2021-07-01 → 2021-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥24.1bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥11.9bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥63.8bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥40.8bn2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥25.0bn2021-07-01 → 2021-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥26.0bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥12.5bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Net income¥42.7bn2021-04-01 → 2021-09-30Cons.Profit loss IFRS
Net income¥25.8bn2021-07-01 → 2021-09-30dCons.Profit loss IFRS
Total assets¥377.7bnat 2022-09-30Cons.Assets IFRS
Total assets¥346.0bnat 2022-03-31Cons.Assets IFRS
Total assets¥308.4bnat 2021-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥86.4bnat 2022-09-30Cons.Liabilities IFRS
Total liabilities¥82.0bnat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥291.3bnat 2022-09-30Cons.Equity IFRS
Net assets / equity¥264.0bnat 2022-03-31Cons.Equity IFRS
Net assets / equity¥237.7bnat 2021-09-30Cons.Equity IFRS
Net assets / equity¥207.3bnat 2021-03-31dCons.Equity IFRS
Equity (owners)¥284.5bnat 2022-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥257.8bnat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥231.4bnat 2021-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥100.2bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥104.3bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥87.0bnat 2021-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥89.1bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥25.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥52.1bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥18.6bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥18.1bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥23.4bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥8.1bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥14.5bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥16.4bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥13.0bn2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥35.442022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥17.582022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥94.062021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥60.092021-04-01 → 2021-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥36.862021-07-01 → 2021-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥35.422022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥17.572022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥93.982021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥60.042021-04-01 → 2021-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥36.832021-07-01 → 2021-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio75.3%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio74.5%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio75.0%at 2021-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 107
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥2.8bn
Reconciling Itemsreconcilingrevenue2022-07-01 → 2022-09-30−¥1.1bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥2.8bn
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2022-09-30−¥1.1bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥701m
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-09-30−¥231m
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue2022-04-01 → 2022-09-30¥8.4bn
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue2022-07-01 → 2022-09-30¥2.9bn
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue external2022-04-01 → 2022-09-30¥7.9bn
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue external2022-07-01 → 2022-09-30¥2.7bn
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥445m
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥179m
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentsegment profit2022-04-01 → 2022-09-30¥3.5bn
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentsegment profit2022-07-01 → 2022-09-30¥634m
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue2022-04-01 → 2022-09-30¥14.0bn
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue2022-07-01 → 2022-09-30¥6.8bn
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue external2022-04-01 → 2022-09-30¥13.7bn
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue external2022-07-01 → 2022-09-30¥6.6bn
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥347m
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥185m
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentsegment profit2022-04-01 → 2022-09-30¥4.2bn
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentsegment profit2022-07-01 → 2022-09-30¥2.0bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue2022-04-01 → 2022-09-30¥42.5bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue2022-07-01 → 2022-09-30¥22.3bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue external2022-04-01 → 2022-09-30¥40.9bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue external2022-07-01 → 2022-09-30¥21.6bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥1.6bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥664m
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentsegment profit2022-04-01 → 2022-09-30¥18.8bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentsegment profit2022-07-01 → 2022-09-30¥10.0bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue2022-04-01 → 2022-09-30¥30.2bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue2022-07-01 → 2022-09-30¥15.3bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue external2022-04-01 → 2022-09-30¥30.2bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue external2022-07-01 → 2022-09-30¥15.3bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥4m
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥2m
jpcrp040300-q2r_E05425-000Overseasreportable segmentsegment profit2022-04-01 → 2022-09-30¥8.1bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentsegment profit2022-07-01 → 2022-09-30¥4.1bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentrevenue2022-04-01 → 2022-09-30¥18.8bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentrevenue2022-07-01 → 2022-09-30¥8.6bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentrevenue external2022-04-01 → 2022-09-30¥18.5bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentrevenue external2022-07-01 → 2022-09-30¥8.6bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥304m
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentsegment profit2022-04-01 → 2022-09-30¥2.3bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentsegment profit2022-07-01 → 2022-09-30¥865m
—segment totalrevenue2022-04-01 → 2022-09-30¥113.9bn
—segment totalrevenue2022-07-01 → 2022-09-30¥55.9bn
—segment totalrevenue external2022-04-01 → 2022-09-30¥111.2bn
—segment totalrevenue external2022-07-01 → 2022-09-30¥54.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-09-30¥2.7bn
—segment totalrevenue intersegment2022-07-01 → 2022-09-30¥1.0bn
—segment totalsegment profit2022-04-01 → 2022-09-30¥36.9bn
—segment totalsegment profit2022-07-01 → 2022-09-30¥17.6bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥2.5bn
Reconciling Itemsreconcilingrevenue2021-07-01 → 2021-09-30−¥1.5bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥2.5bn
Reconciling Itemsreconcilingrevenue intersegment2021-07-01 → 2021-09-30−¥1.5bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥520m
Reconciling Itemsreconcilingsegment profit2021-07-01 → 2021-09-30−¥376m
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue2021-04-01 → 2021-09-30¥8.2bn
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue2021-07-01 → 2021-09-30¥3.3bn
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue external2021-04-01 → 2021-09-30¥7.8bn
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue external2021-07-01 → 2021-09-30¥3.0bn
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥364m
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥338m
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentsegment profit2021-04-01 → 2021-09-30¥3.4bn
jpcrp040300-q2r_E05425-000Career Solutionreportable segmentsegment profit2021-07-01 → 2021-09-30¥979m
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue2021-04-01 → 2021-09-30¥10.1bn
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue2021-07-01 → 2021-09-30¥5.3bn
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue external2021-04-01 → 2021-09-30¥9.6bn
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue external2021-07-01 → 2021-09-30¥5.0bn
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥483m
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥288m
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentsegment profit2021-04-01 → 2021-09-30¥2.1bn
jpcrp040300-q2r_E05425-000Evidence Solutionreportable segmentsegment profit2021-07-01 → 2021-09-30¥1.2bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue2021-04-01 → 2021-09-30¥38.4bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue2021-07-01 → 2021-09-30¥19.5bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue external2021-04-01 → 2021-09-30¥37.1bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue external2021-07-01 → 2021-09-30¥18.8bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥1.3bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥622m
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentsegment profit2021-04-01 → 2021-09-30¥16.7bn
jpcrp040300-q2r_E05425-000Medical Platformreportable segmentsegment profit2021-07-01 → 2021-09-30¥8.5bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue2021-04-01 → 2021-09-30¥24.4bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue2021-07-01 → 2021-09-30¥11.7bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue external2021-04-01 → 2021-09-30¥24.4bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue external2021-07-01 → 2021-09-30¥11.7bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥12m
jpcrp040300-q2r_E05425-000Overseasreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥1m
jpcrp040300-q2r_E05425-000Overseasreportable segmentsegment profit2021-04-01 → 2021-09-30¥38.1bn
jpcrp040300-q2r_E05425-000Overseasreportable segmentsegment profit2021-07-01 → 2021-09-30¥25.2bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentrevenue2021-04-01 → 2021-09-30¥17.5bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentrevenue2021-07-01 → 2021-09-30¥12.2bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentrevenue external2021-04-01 → 2021-09-30¥17.2bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentrevenue external2021-07-01 → 2021-09-30¥11.9bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥238m
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥238m
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentsegment profit2021-04-01 → 2021-09-30¥2.6bn
jpcrp040300-q2r_E05425-000Site Solutionreportable segmentsegment profit2021-07-01 → 2021-09-30¥2.0bn
—segment totalrevenue2021-04-01 → 2021-09-30¥98.6bn
—segment totalrevenue2021-07-01 → 2021-09-30¥52.0bn
—segment totalrevenue external2021-04-01 → 2021-09-30¥96.2bn
—segment totalrevenue external2021-07-01 → 2021-09-30¥50.5bn
—segment totalrevenue intersegment2021-04-01 → 2021-09-30¥2.4bn
—segment totalrevenue intersegment2021-07-01 → 2021-09-30¥1.5bn
—segment totalsegment profit2021-04-01 → 2021-09-30¥62.9bn
—segment totalsegment profit2021-07-01 → 2021-09-30¥37.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 824
ItemContextValueUnit
Other current assets ca IFRSPrior1YearInstant6779000000JPY
Other current assets ca IFRSCurrentQuarterInstant6661000000JPY
Current assets IFRSPrior1YearInstant198874000000JPY
Current assets IFRSCurrentQuarterInstant197413000000JPY
Property plant and equipment IFRSPrior1YearInstant12540000000JPY
Property plant and equipment IFRSCurrentQuarterInstant14779000000JPY
Goodwill IFRSPrior1YearInstant57821000000JPY
Goodwill IFRSCurrentQuarterInstant67699000000JPY
Intangible assets IFRSPrior1YearInstant25081000000JPY
Intangible assets IFRSCurrentQuarterInstant36047000000JPY
Investments accounted for using equity method IFRSPrior1YearInstant37152000000JPY
Investments accounted for using equity method IFRSCurrentQuarterInstant44715000000JPY
Financial assets measured at fair value nca IFRSPrior1YearInstant7596000000JPY
Financial assets measured at fair value nca IFRSCurrentQuarterInstant10471000000JPY
Other financial assets nca IFRSPrior1YearInstant2745000000JPY
Other financial assets nca IFRSCurrentQuarterInstant2424000000JPY
Deferred tax assets IFRSPrior1YearInstant2137000000JPY
Deferred tax assets IFRSCurrentQuarterInstant2123000000JPY
Other non current assets nca IFRSPrior1YearInstant2034000000JPY
Other non current assets nca IFRSCurrentQuarterInstant2077000000JPY
Non current assets IFRSPrior1YearInstant147107000000JPY
Non current assets IFRSCurrentQuarterInstant180334000000JPY
Assets IFRSPrior1YearInstant345981000000JPY
Assets IFRSCurrentQuarterInstant377747000000JPY
Trade and other payables cl IFRSPrior1YearInstant28978000000JPY
Trade and other payables cl IFRSCurrentQuarterInstant30232000000JPY
Income taxes payable cl IFRSPrior1YearInstant11123000000JPY
Income taxes payable cl IFRSCurrentQuarterInstant10256000000JPY
Provisons for customer loyalty program cl IFRSPrior1YearInstant2739000000JPY
Provisons for customer loyalty program cl IFRSCurrentQuarterInstant2987000000JPY
Other financial liabilities cl IFRSPrior1YearInstant3812000000JPY
Other financial liabilities cl IFRSCurrentQuarterInstant4449000000JPY
Other current liabilities cl IFRSPrior1YearInstant10565000000JPY
Other current liabilities cl IFRSCurrentQuarterInstant9340000000JPY
Total current liabilities IFRSPrior1YearInstant57216000000JPY
Total current liabilities IFRSCurrentQuarterInstant57264000000JPY
Other financial liabilities ncl IFRSPrior1YearInstant6674000000JPY
Other financial liabilities ncl IFRSCurrentQuarterInstant8351000000JPY
Deferred tax liabilities IFRSPrior1YearInstant13479000000JPY
Deferred tax liabilities IFRSCurrentQuarterInstant16096000000JPY
Other non current liabilities ncl IFRSPrior1YearInstant4658000000JPY
Other non current liabilities ncl IFRSCurrentQuarterInstant4731000000JPY
Non current labilities IFRSPrior1YearInstant24811000000JPY
Non current labilities IFRSCurrentQuarterInstant29177000000JPY
Liabilities IFRSPrior1YearInstant82027000000JPY
Liabilities IFRSCurrentQuarterInstant86441000000JPY
Share capital IFRSPrior1YearInstant29129000000JPY
Share capital IFRSCurrentQuarterInstant29166000000JPY
Capital surplus IFRSPrior1YearInstant29704000000JPY
Capital surplus IFRSCurrentQuarterInstant29742000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass